Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.
U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...
After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...
Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...
Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...
Here are the five things you need to know in local business news to start your workday, including SBA offices exiting Boston, ...
According to Halozyme, the new version of Keytruda infringes on its patents, the report said. USAID cuts put tuberculosis response in peril, WHO says The Trump administration's decision to pause U.S.
One of the few drug developers based in Worcester is leaving Wormtown for Waltham. Also, Novo Nordisk and Eli Lilly have ...
Last week, Eli Lilly said it would cut the monthly price of its starter ... The AP is solely responsible for all content.
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results